Johnson and Johnson Newswire (Page 5)

Comprehensive Real-Time News Feed for Johnson and Johnson. (Page 5)

Results 81 - 100 of 17,777 in Johnson and Johnson

  1. Xarelto Is the Least Costly Novel Anticoagulant, AIS Researchers FindRead the original story

    Tuesday Jan 27 | PRWeb

    Xarelto's low price translates into the lowest out-of-pocket costs to members, according to analysis conducted by the editors of Atlantic Information Services's new online resource Rx Benefit Design Data. Xarelto, a novel oral anticoagulant manufactured by BayerHealthcare AG and Johnson & Johnson division Janssen Pharmaceuticals, Inc., has the lowest retail cost when compared with two of its major competitors, according a random sampling conducted by the editors of Atlantic Information Services, Inc.'s Rx Benefit Design Data , a new online subscription database with detailed data, news and insight on prescription drug benefit parameters of health plans.

    Comment?

  2. P&G fiscal 2Q earnings drop 31 pct, hurt by exchange ratesRead the original story w/Photo

    Aug 2, 2010 | KNDO

    Procter & Gamble's second-quarter earnings sank 31 percent as the strong U.S. dollar cut into the performance of the world's largest consumer products maker. The Cincinnati company, which sells products ranging from Tide detergent to Crest toothpaste, said Tuesday that exchange rates will remain a challenge well into fiscal 2015, especially in the second half of its year.

    Comment?

  3. Talcum Powder Lawsuit News Added to Attorney WebsiteRead the original story w/Photo

    Tuesday Jan 27 | PRWeb

    In order to provide clear news updates on talcum powder lawsuits to the public, attorneys at the Onder Law Firm providing talcum powder lawsuit representations have expanded their website to include a news page at the Talcum Powder Ovarian Cancer Center website. Attorneys providing weekly talcum powder lawsuit news updates at their Talcum Powder Ovarian Cancer Center website have created a separate news page in order to provide the public with easy access to talcum powder lawsuit news.

    Comment?

  4. IDT911 Consulting Grows Cybersecurity and Breach Expertise with...Read the original story

    Tuesday Jan 27 | PRWeb

    IDT911 Consulting , a subsidiary of Ariz. based IDT911 and a leader in data risk protection, management, and privacy compliance, today announced three additions to its team of consultants.

    Comment?

  5. Chipotle Shares Already Pricing In 5,000 LocationsRead the original story w/Photo

    Tuesday Jan 27 | Seeking Alpha

    I think shares are already pricing in 5,000 locations, and that is beyond saturation; I don't see a bullish scenario. Shareholders of burrito giant Chipotle have certainly enjoyed the past two years.

    Comment?

  6. Museum Dr. Guislain and Janssen Research & Development, LLC Issue...Read the original story

    Tuesday Jan 27 | Sys-Con Media

    The award honors an individual, project or organization that has made an exceptional contribution to reduce stigma associated with mental illness. Nominations from people and organizations across the globe can be submitted at www.drguislainaward.org , and will be accepted until .

    Comment?

  7. Former FDA commissioner might testify against J&JRead the original story w/Photo

    Monday Jan 26 | Philly.com

    Former U.S. Food and Drug Administration Commissioner David Kessler may testify for the plaintiff in a lawsuit against drugmaker Johnson & Johnson that is being heard in Philadelphia Common Pleas Court. This is not the first trial of a case involving the antipsychotic drug Risperdal, which was approved more than a decade ago, mainly for schizophrenia.

    Comment?

  8. After big Box debut, next 4 Bay Area IPOs are all in life sciencesRead the original story w/Photo

    Monday Jan 26 | Business Journal

    Redwood City-based catheter company Avinger, started by cardiologist John D. Simpson in 2007, hopes to raise up to $74 million in an IPO this week. The IPO spotlight shifts from tech to life sciences in the Bay Area for the next two weeks when four offerings are expected from health-related companies.

    Comment?

  9. Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine RegimenRead the original story w/Photo

    Tuesday Jan 6 | Drugs.com

    Jan. 6, 2015 - Johnson & Johnson today announced the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies. The trial is being led by the Oxford Vaccine Group, part of the University of Oxford Department of Paediatrics.

    Comment?

  10. How to Tell if a Dividend Is SafeRead the original story w/Photo

    Monday Jan 26 | The Motley Fool

    When buying dividend stocks, the safety of the dividend is even more important than the payout amount. After all, what's the point of investing to create an income stream if that income can vanish at any time? With that in mind, there are both good signs and red flags you should look for when evaluating a dividend stock.

    Comment?

  11. Keep safe with proper medication storageRead the original story

    Monday Jan 26 | Fitchburg Star

    It was not until years later that I understood the reason for this ad campaign; serving a bigger role in the community by teaching people the importance of cleaning their medicine cabinets. Those ads haven't been around for 30 years, but the message of throwing away old medication is still relevant today.

    Comment?

  12. Former FDA commissioner might testify against J&J in Philly caseRead the original story w/Photo

    Monday Jan 26 | Philly.com

    Former Food and Drug Administration Commissioner David Kessler might testify for the plaintiff in coming days in a lawsuit against drugmaker Johnson & Johnson that is being heard in Philadelphia Court of Common Pleas. This is not the first trial of a case involving the antipsychotic drug Risperdal, which was approved more than a decade ago mainly for schizophrenia.

    Comment?

  13. How Much 'Extra' Return Are You Getting If You Reinvest Dividends?Read the original story w/Photo

    Monday Jan 26 | Seeking Alpha

    Reinvesting dividends generates still larger returns. Over long time periods, price return may provide less than half the total return that you receive from an investment.

    Comment?

  14. Jim Cramer Answers Twitter (TWTR) Questions on Johnson & Johnson, Alcoa, Mobileye, and FacebookRead the original story w/Photo

    Monday Jan 26 | TheStreet.com

    Cramer says he thinks Mobileye was a speculative stock with some interesting technologies, but he would rather play the interesting technologies in Harman Industries STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

    Comment?

  15. Intuitive Surgical Set To Regain Momentum In 2015Read the original story w/Photo

    Monday Jan 26 | Seeking Alpha

    Fourth quarter results exceeded expectations as sequential system placement growth has returned and procedure growth continues at a double-digit pace. Ongoing utilization growth outside of prostatectomy, hysterectomy, and gall bladder procedures is vital if the shares are to continue to outperform.

    Comment?

  16. Dutch FA president Michael van Praag to stand against Sepp Blatter for FIFA presidencyRead the original story w/Photo

    Monday Jan 26 | Mirror.co.uk

    The 67-year-old is set to join Prince Ali Bin Al Hussein and possibly Jerome Champagne as confirmed candidates for the position Michael van Praag, the president of the Dutch FA, has announced his intentions to stand against Sepp Blatter for the FIFA presidency. In a statement released by the Dutch FA, Van Praag says he has the required support of five different associations to challenge for the position.

    Comment?

  17. Interesting January 2017 Stock Options for Johnson & JohnsonRead the original story w/Photo

    Monday Jan 26 | Forbes.com

    Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson . So this week we highlight one interesting put contract, and one interesting call contract, from the January 2017 expiration for JNJ.

    Comment?

  18. Sirona Biochem Invited To Present At Dose Of The Valley Conference, San FranciscoRead the original story

    Sunday Jan 25 | BioSpace

    January 26, 2015 - Sirona Biochem Corp. announces that it has been chosen by the Consulate General of Canada to present at the Dose of the Valley conference on February 3-4 in San Francisco, California. This unique conference will give Sirona the opportunity to showcase its platform technology and some of the latest study results to an audience of key industry players, such as: L'Oreal, Merck and Johnson & Johnson.

    Comment?

  19. Cramer Answers Twitter Questions on Mobileye, Opko Health, AlcoaRead the original story w/Photo

    Monday Jan 26 | TheStreet.com

    Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

    Comment?

  20. Icahn launches proxy fight against GannettRead the original story w/Photo

    Monday Jan 26 | Financial News & Daily Record

    As if Gannett Co. Inc. didn't already have its hands full dealing with plans to split its broadcasting and publishing businesses into separate companies, now it's facing a proxy fight with activist investor Carl Icahn.

    Comment?